Streetbeat News

Regulatory

ESAIY

MRK

Merck and Eisai have announced that their Phase 3 LEAP-010 trial evaluating KEYTRUDA plus LENVIMA did not result in an overall survival benefit for patients. The study will be closed due to the low likelihood of reaching the protocol-specified threshold for statistical significance.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 10:19 am

SPY

VGK

A spokesman for Russian President Vladimir Putin has dismissed Western claims that Yevgeny Prigozhin, a businessman with close ties to the Kremlin, was killed on Putin's orders, calling them an 'absolute lie'.

Portfolio Pulse from Charles Gross

August 25, 2023 | 10:16 am

BTCUSD

Arthur Hayes, co-founder of BitMEX, has stated that Bitcoin's value is set to rise due to the Federal Reserve's current strategies against inflation. He believes that Bitcoin, with its finite supply, will benefit as the 'denominator of fiat toilet paper grows'. Hayes also criticized the ongoing crypto crackdown in the US and the West, and questioned the contrasting treatment received by different entities seeking approval for Bitcoin-related ventures.

Portfolio Pulse from Mehab Qureshi

August 25, 2023 | 10:15 am

SPCE

Elon Musk, CEO of SpaceX, tweeted about the International Traffic in Arms Regulations (ITAR) law, stating that US companies with advanced weapons technology, such as rockets with intercontinental range, must hire people who are permanent American residents.

Portfolio Pulse from Charles Gross

August 25, 2023 | 9:34 am

NVO

Novo Nordisk announced positive results from the phase 3 STEP HFpEF trial of semaglutide 2.4 mg, showing significant reductions in heart failure-related symptoms and physical limitations, as well as weight loss in adults with heart failure with preserved ejection fraction (HFpEF) and obesity. The findings were presented at the European Society of Cardiology Congress and published in the New England Journal of Medicine.

Portfolio Pulse from Charles Gross

August 25, 2023 | 9:26 am

NVO

Novo Nordisk's CEO has stated that the company is seeking reimbursement deals with European governments for its weight-loss drug, Wegovy. The demand for Wegovy is so strong that different commercial strategies are needed to reach the most needy patients.

Portfolio Pulse from Charles Gross

August 25, 2023 | 9:21 am

INDA

TSLA

India is considering a proposal to cut import duties for electric vehicle (EV) manufacturers who commit to investing in the country. This move comes after Tesla's push for lower duties. The policy could be implemented as early as 2023.

Portfolio Pulse from Charles Gross

August 25, 2023 | 8:52 am

EWG

VGK

Germany's business expectations for August came in at 82.6, lower than the estimated 83.8 and the prior figure of 83.6.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 8:02 am

EWG

VGK

Germany's Ifo Business Climate Index for August has been reported at 85.7, lower than the estimated 86.7 and the prior figure of 87.3.

Portfolio Pulse from Benzinga Newsdesk

August 25, 2023 | 8:01 am

GOOG

GOOGL

A U.S. District Judge has dismissed a lawsuit filed by the Republican National Committee (RNC) against Alphabet Inc.’s Google, alleging that Google was censoring donation emails by routing them to Gmail users’ spam folders. The ruling was based on the interpretation of Section 230 of the Communications Decency Act, which protects internet companies from liability for content posted on their platforms. The RNC has been granted the opportunity to revise and refile its complaint.

Portfolio Pulse from Ananya Gairola

August 25, 2023 | 6:29 am